Financial Advisors Network’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,092
Closed -$3.22M 205
2025
Q4
$3.22M Sell
14,092
-62
-0.4% -$14.1K 0.44% 44
2025
Q3
$3.28M Sell
14,154
-416
-3% -$84.7K 0.46% 44
2025
Q2
$2.7M Buy
14,570
+216
+2% +$40.1K 0.41% 48
2025
Q1
$3.01M Buy
14,354
+10,558
+278% +$2.05M 0.5% 39
2024
Q4
$675K Buy
+3,796
New +$698K 0.11% 84
2023
Q4
$409K Buy
2,636
+1,044
+66% +$152K 0.08% 105
2023
Q3
$237K Buy
+1,592
New +$234K 0.05% 139
2021
Q1
Sell
-17,717
Closed -$1.9M 112
2020
Q4
$1.9M Buy
17,717
+794
+5% +$76.3K 0.65% 38
2020
Q3
$1.48M Sell
16,923
-1,071
-6% -$101K 0.58% 40
2020
Q2
$1.77M Sell
17,994
-522
-3% -$46K 0.72% 32
2020
Q1
$1.41M Buy
+18,516
New +$1.58M 0.67% 32
2017
Q1
Sell
-89
Closed -$5.38K 92
2016
Q4
$5.38K Buy
+89
New +$5.43K ﹤0.01% 326

Other funds holding ABBV

Financial Advisors Network's ABBV Position: Q1 2026 in Review

Financial Advisors Network sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 14,092 shares — an estimated $3.22M sold.

Financial Advisors Network first reported a position in ABBV in Q4 2016 and held it in 12 quarters. The position peaked at $3.28M in Q3 2025. 4,075 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Financial Advisors Network reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Financial Advisors Network sold 14,092 AbbVie shares in Q1 2026, an estimated $3.22M.
  • Financial Advisors Network first reported a position in AbbVie in Q4 2016 and held it in 12 quarters.
  • Financial Advisors Network's AbbVie position peaked at $3.28M in Q3 2025.
  • 4,075 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Financial Advisors Network's 13F filing for Q1 2026, filed 15 May 2026.